REVITALIST LIFESTYLE AND WELLNESS LTD. (“Revitalist” or the “Company”) (CSE: CALM) (OTC: RVLWF) (FSE: 4DO) is pleased to announce that it has executed an asset purchase agreement (“Agreement”) dated January 11, 2022, to acquire a Ketamine clinic located in Jacksonville, Florida (“Acquisition”). Revitalist had previously announced the Acquisition non-binding letter of intent on October 27, 2021. This Acquisition represents the ninth clinic for the Company and is expected to commence under the Revitalist brand by February 1, 2022. The Jacksonville clinic was formed in 2017 and continues to be managed by Dr. Nicholas Kalynych who has over 30 years of experience in health care.

Dr. Nicholas Kalynych commented: “I am very pleased to be teaming up with Revitalist to accelerate growth of the practice in Jacksonville. With this acquisition complete, we are now positioned to significantly expand our service offerings and patient count, which will provide the Jacksonville community greater access to care.”

Kathryn Walker, CEO of Revitalist, commented: “With the closing of this acquisition, Revitalist will have nine clinics operating in six states. We are well on our way to executing our growth plans. On behalf of the entire company, I would like to formally welcome Dr. Kalynych and his team to Revitalist. We look forward to implementing our business model in Jacksonville and utilizing the decades of experience provided by Dr. Kalynych to offer exceptional treatments to the community.”

Pursuant to the terms of the Agreement, the consideration for the Acquisition is $100,000 USD. The consideration payable is $60,000 USD in cash and $40,000 in common shares. The share consideration will be issued at the greater of $0.50/share and the 20-day volume weighted average share price preceding the issue date and will be issued 50% in 12 months and 50% in 24 months following the closing of the Acquisition.

ABOUT REVITALIST LIFESTYLE AND WELLNESS LTD.

Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTC: RVLWF) (FSE: 4DO) is a publicly traded company, headquartered in Knoxville, Tennessee, with seven clinics operating across the United States and expanding. Revitalist is dedicated to empowering individuals toward an improved quality of well-being through a combination of comprehensive care and future-centric treatments provided by medical professionals, mental health experts, and chronic pain specialists. Since opening their first clinic in 2018, Revitalist has provided thousands of infusions for patients suffering from treatment-resistant conditions. Additionally, Revitalist offers a number of lifestyle optimization services and vitamin infusions that can bring anyone closer to total wellness. For additional information and to be added to the Company’s mailing list, please click here .

Twitter: @RevitalistCorp
Facebook: @RevitalistLifestyleandWellnessLtd.
Instagram: @RevitalistCorp
LinkedIn: @RevitalistLifestyleAndWellnessLtd

On Behalf of the Board:
Kathryn Walker
Chief Executive Officer

Forward Looking Statements

This news release contains forward-looking statements and information within the meaning of applicable securities legislation. Often, but not always, forward-looking statements and information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward looking statements or information involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Revitalist to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements or information contained in this news release.

Risks, uncertainties, and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220112005347/en/

For further information:
Revitalist Lifestyle and Wellness Ltd.
Email: [email protected]
Tel: (865) 585-8414

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

REVITALIST LIFESTYLE AND WELLNESS LTD. (“Revitalist” or the “Company”) (CSE: CALM) (OTC: RVLWF) (FSE: 4DO) is pleased to announce that President & Chief Executive Officer, Kathryn Walker, will present virtually at the H.C. Wainwright Bioconnect Conference taking place on January 10-13, 2022.

A webcast of Revitalist’s presentation will be available on-demand from Monday, January 10 ^th at 7:00a.m. ET via this link: https://journey.ct.events/view/83082b1a-dbbf-411d-9f85-8924ab783854 and a recording of the webcast can be viewed through the above link for 90 days.

To schedule a one-on-one meeting with Revitalist’s management team, please contact [email protected]

The Company also announces it has granted a total of 430,000 stock options and 130,000 restricted share units to certain employees and consultants pursuant to the terms of the Company’s long term incentive plan (“Plan”). The stock options are exercisable at a price of $0.20 per share.

ABOUT REVITALIST LIFESTYLE AND WELLNESS LTD.

Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTC: RVLWF) (FSE: 4DO) is a publicly traded company, headquartered in Knoxville, Tennessee, with seven clinics operating across the United States and expanding. Revitalist is dedicated to empowering individuals toward an improved quality of well-being through a combination of comprehensive care and future-centric treatments provided by medical professionals, mental health experts, and chronic pain specialists. Since opening their first clinic in 2018, Revitalist has provided thousands of infusions for patients suffering from treatment-resistant conditions. Additionally, Revitalist offers a number of lifestyle optimization services and vitamin infusions that can bring anyone closer to total wellness. For additional information and to be added to the Company’s mailing list, please click here .

Twitter: @RevitalistCorp
Facebook: @RevitalistLifestyleandWellnessLtd.
Instagram: @RevitalistCorp
LinkedIn: @RevitalistLifestyleAndWellnessLtd

On Behalf of the Board
Kathryn Walker
Chief Executive Officer

Forward Looking Statements

This news release contains forward-looking statements and information within the meaning of applicable securities legislation. Often, but not always, forward-looking statements and information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward looking statements or information involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Revitalist to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements or information contained in this news release.

Risks, uncertainties, and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220107005082/en/

Revitalist Lifestyle and Wellness Ltd.
Email: [email protected]
Tel: (865) 585-8414

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Researchers believe that psychedelics may revolutionize mental health treatments, but FDA-approved psychedelics remain out of reach—with one exception. Unlike psilocybin or MDMA, ketamine is FDA-approved for anesthesia during medical procedures, opening the door to off-label use as a treatment for depression and other mental illnesses.

With the FDA’s approval of Spravato and a growing body of research supporting ketamine, patients are increasingly turning toward these clinics to solve their unmet medical needs.

Ketamine clinics charge between $450 and $500 per treatment, with each patient needing approximately six treatments. In aggregate, some analysts estimate that the market is already worth north of $16 billion per year, with rapid growth possible over the coming years. 

Let’s take a look at three ways that you can invest in ketamine clinics.

Revitalist Lifestyle

Revitalist Lifestyle & Wellness Ltd. (CSE: CALM) (OTC: RVLWF) (FSE:4DO) is one of the most exciting pure-plays in the ketamine clinic space. Since opening its first clinic in 2018, the company has built a network of eight clinics across four states, with two additional clinics to open by the end of the year in Bethesda, MD and a second Knoxville, TN location. In addition, January 1, 2022 will see two newly acquired clinics in Richmond, VA. and Jacksonville, FL, with more than 60,650 sq. ft. of space and clinical capacity for more than 120 treatment rooms. All of Revitalist’s treatments are provided by certified registered nurse anesthetists with ketamine experience and mental health or psychiatric practitioners licensed to administer the drug.

Last quarter, the company reported $1.55 million in revenue and $1.17 million in gross income for the ten months leading up to October 31, 2021. Management believes that its existing 120 treatment rooms could generate upwards of $60 million in annual revenue, while it plans to open 50 clinics in 2022 before reaching 150 clinics by 2025.

The company also plans to launch a telemedicine platform over the coming months. These efforts could significantly expand its addressable market across geographies. And with its 60% acquisition of Revitaland Meta Tech Inc., the platform could expand to include virtual clinics in the metaverse—a rapidly growing innovation spearheaded by Facebook.

Click here to learn more about investing in Revitalist

Field Trip Health

Field Trip Health Ltd. (NASDAQ: FTRP) is the largest ketamine clinic operator with a $150 million market capitalization. In addition to psychedelic drug development, the company operates six clinics and plans to expand to 75 locations by 2024. These clinics provide psychedelic-assisted psychotherapy with the help of ketamine.

The company also provides a digital platform to support patients through their therapeutic journey. The platform offers mood monitoring, mindfulness tools, information, and guided meditations, along with video calls and asynchronous text communication. The goal is to help collect data and improve patient outcomes.

Novamind

Novamind Inc. (CSE: NM) (OTC: NVMDF) operates a network of six ketamine clinics and clinical research sites in Utah. In 2022, the company plans to add new clinics in Utah and expand into Arizona for a total of ten clinics. These will include a center for immersive psychedelic experiences in Park City, Utah, a world-class travel and wellness destination.

In addition to ketamine therapies, the company operates a full-service psychedelic contract research organization (CRO) with three clinical research sites and a DEA Schedule 1 license for psilocybin research. These facilities could help it play a role in the study and eventual approval of psilocybin, MDMA, and other psychedelic therapies.

Looking Ahead

Ketamine clinics are quickly becoming a multi-billion dollar business driven by rapidly growing demand. Investors interested in the space have several options, including pure-plays like Revitalist Lifestyle & Wellness Ltd. (CSE: CALM) (OTC: RVLWF). 

For more information, visit the company’s website or download their investor presentation.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.